CurrentEndo coverage · page 49 of 55

Diabetes, Obesity and Metabolism

Briefs 1,921–1,960 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

Diabetes Obes Metab14 Aug 2023
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial
Randomized controlled trialT2D & other
Diabetes Obes Metab14 Aug 2023
Efficacy of anti‐CD3 monoclonal antibodies in delaying the progression of recent‐onset type 1 diabetes mellitus: A systematic review, meta‐analyses and meta‐regression
Meta-analysisT1D
Diabetes Obes Metab10 Aug 2023
Post‐initiation predictors of discontinuation of the sodium‐glucose cotransporter‐2 inhibitors: A comparative cohort study from the United Kingdom
Cohort studyT2D & other
Diabetes Obes Metab8 Aug 2023
Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes
Randomized controlled trialTechnology
Diabetes Obes Metab8 Aug 2023
Labisia pumila standardized extract ( SKF7 ®) reduces percentage of waist circumference and waist‐to‐height ratio in individuals with obesity
Randomized controlled trialObesity
Diabetes Obes Metab7 Aug 2023
Glucose‐lowering drug use in migrants and native Danes with type 2 diabetes: Disparities in combination therapy and drug types
Cross-sectional studyT2D & other
Diabetes Obes Metab2 Aug 2023
Remnant cholesterol, but not low‐density lipoprotein cholesterol, is associated with intra‐pancreatic fat deposition
Cross-sectional studyLipids & liver
Diabetes Obes Metab2 Aug 2023
Effects of once‐weekly glucagon‐like peptide‐1 receptor agonists on type 2 diabetes mellitus complicated with coronary artery disease: Potential role of the renin‐angiotensin system
Meta-analysisT2D & other
Diabetes Obes Metab2 Aug 2023
Cardiovascular prevention with glucose‐lowering drugs in type 2 diabetes: An evidence‐based approach to the categories of primary and secondary prevention
Meta-analysisT2D & other
Diabetes Obes Metab2 Aug 2023
Initial antibiotic therapy for postoperative moderate or severe diabetic foot infections: Broad versus narrow spectrum, empirical versus targeted
Cohort studyComplications
Diabetes Obes Metab31 Jul 2023
Comparative efficacy of digitally assisted interventions for glycated haemoglobin levels among patients with type 2 diabetes: A systematic review and component network Meta‐Analysis
Meta-analysisT2D & other
Diabetes Obes Metab28 Jul 2023
Safety of sodium‐glucose co‐transporter‐2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes
Cohort studyT2D & other
Diabetes Obes Metab28 Jul 2023
The associations of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors as add‐on to metformin with fracture risk in patients with type 2 diabetes mellitus
Cohort studyT2D & other
Diabetes Obes Metab26 Jul 2023
Associations of lipoprotein subclasses with risk of all‐cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study
Cohort studyT2D & other
Diabetes Obes Metab24 Jul 2023
Hypoglycaemia induces a sustained pro‐inflammatory response in people with type 1 diabetes and healthy controls
Mechanistic studyT1D
Diabetes Obes Metab24 Jul 2023
Evaluating the clinical effectiveness and safety of insulin glargine 300 U/ mL in individuals with type 2 diabetes uncontrolled on basal insulin: A real‐world evidence study from Saudi Arabia ( EVOLUTION )
Cohort studyT2D & other
Diabetes Obes Metab24 Jul 2023
Adaptive bolus calculators for people with type 1 diabetes: A systematic review
Meta-analysisTechnology
Diabetes Obes Metab17 Jul 2023
Combining polygenic risk scores and human leukocyte antigen variants for personalized risk assessment of type 1 diabetes in the Taiwanese population
Case-control studyT1D
Diabetes Obes Metab17 Jul 2023
Fat‐to‐muscle ratio is associated with insulin resistance and cardiometabolic disorders in adults with type 1 diabetes mellitus
Cross-sectional studyT1D
Diabetes Obes Metab14 Jul 2023
Adipose tissue‐derived FABP4 mediates glucagon‐stimulated hepatic glucose production in gestational diabetes
Mechanistic studyDiabetes in pregnancy
Diabetes Obes Metab12 Jul 2023
Healthy lifestyle and all‐cause and cause‐specific dementia in individuals with type 2 diabetes and the roles of diabetes duration and insulin use in UK Biobank cohort
Cohort studyT2D & other
Diabetes Obes Metab12 Jul 2023
Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD‐AF registry
Cohort studyT2D & other
Diabetes Obes Metab12 Jul 2023
Effects of sodium‐glucose co‐transporter‐2 inhibitors by background cardiovascular medications: A systematic review and meta‐analysis
Meta-analysisT2D & other
Diabetes Obes Metab12 Jul 2023
Testing for associations between HbA1c levels, polygenic risk and brain health in UK Biobank ( N = 39 283)
Cross-sectional studyT2D & other
Diabetes Obes Metab12 Jul 2023
Cysteine‐lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose‐finding study
Research articleObesity
Diabetes Obes Metab10 Jul 2023
Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes
Cohort studyTechnology
Diabetes Obes Metab10 Jul 2023
Variants within the LPL gene confer susceptility to diabetic kidney disease and rapid decline in kidney function in Chinese patients with type 2 diabetes
Research articleComplications
Diabetes Obes Metab9 Jul 2023
A model‐based approach to predict individual weight loss with semaglutide in people with overweight or obesity
Diagnostic or prognostic studyObesity
Diabetes Obes Metab7 Jul 2023
Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes
Secondary analysisT2D & other
Diabetes Obes Metab7 Jul 2023
Incidence of atrial and ventricular arrhythmias in obese patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
Cohort studyObesity
Diabetes Obes Metab7 Jul 2023
Relationship between the magnitude of body mass index reductions and remission in patients with type 2 diabetes in real world settings: Analysis of nationwide patient registry in Japan ( JDDM 74)
Cohort studyT2D & other
Diabetes Obes Metab6 Jul 2023
Cost‐effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes
Research articleT2D & other
Diabetes Obes Metab6 Jul 2023
Development and validation of a real‐world model to predict 1‐year Level 3 (severe) hypoglycaemia risk in adults with diabetes (the iNPHORM study, United States)
Diagnostic or prognostic study
Diabetes Obes Metab6 Jul 2023
Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24‐week, randomized, double‐blind, placebo‐controlled trial
Randomized controlled trialT2D & other
Diabetes Obes Metab4 Jul 2023
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study
Secondary analysisComplications
Diabetes Obes Metab4 Jul 2023
Safety of sodium‐glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
Meta-analysisT2D & other
Diabetes Obes Metab3 Jul 2023
Prescription of guideline‐directed medical therapies in patients with diabetes and chronic kidney disease from the CURE‐CKD Registry, 2019‐2020
Cohort studyT2D & other
Diabetes Obes Metab3 Jul 2023
Contemporary trends in the utilization of second‐line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom
Cohort studyT2D & other
Diabetes Obes Metab3 Jul 2023
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes
Secondary analysisT2D & other
Diabetes Obes Metab29 Jun 2023
A micro‐randomized pilot study to examine the impact of just‐in‐time nudging on after‐dinner snacking in adults with type 2 diabetes: A study protocol
Trial designT2D & other

All 2,200 Briefs in ExploreShowing Briefs 1,921–1,960 of 2,200, newest first